Copyright Reports & Markets. All rights reserved.

Global Artificial Intelligence Drug R&D Market Size, Status and Forecast 2020-2026

Request for Sample of this report
Buy now

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2020 VS 2026
    • 1.2.2 AI Platfrom
    • 1.2.3 Analytics Service
  • 1.3 Market by Application
    • 1.3.1 Global Artificial Intelligence Drug R&D Market Share by Application: 2020 VS 2026
    • 1.3.2 Drug Discovery
    • 1.3.3 Precision Medicine
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Global Growth Trends

  • 2.1 Global Artificial Intelligence Drug R&D Market Perspective (2015-2026)
  • 2.2 Global Artificial Intelligence Drug R&D Growth Trends by Regions
    • 2.2.1 Artificial Intelligence Drug R&D Market Size by Regions: 2015 VS 2020 VS 2026
    • 2.2.2 Artificial Intelligence Drug R&D Historic Market Share by Regions (2015-2020)
    • 2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Regions (2021-2026)
  • 2.3 Industry Trends and Growth Strategy
    • 2.3.1 Market Trends
    • 2.3.2 Market Drivers
    • 2.3.3 Market Challenges
    • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Top Artificial Intelligence Drug R&D Players by Market Size
    • 3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2015-2020)
    • 3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2015-2020)
  • 3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue
  • 3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio
    • 3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2019
  • 3.5 Key Players Artificial Intelligence Drug R&D Area Served
  • 3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service
  • 3.7 Date of Enter into Artificial Intelligence Drug R&D Market
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Artificial Intelligence Drug R&D Breakdown Data by Type (2015-2026)

  • 4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2015-2020)
  • 4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2021-2026)

5 Artificial Intelligence Drug R&D Breakdown Data by Application (2015-2026)

  • 5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2015-2020)
  • 5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2021-2026)

6 North America

  • 6.1 North America Artificial Intelligence Drug R&D Market Size (2015-2026)
  • 6.2 North America Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
  • 6.3 North America Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
  • 6.4 North America Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
    • 6.4.1 United States
    • 6.4.2 Canada

7 Europe

  • 7.1 Europe Artificial Intelligence Drug R&D Market Size (2015-2026)
  • 7.2 Europe Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
  • 7.3 Europe Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
  • 7.4 Europe Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
    • 7.4.1 Germany
    • 7.4.2 France
    • 7.4.3 U.K.
    • 7.4.4 Italy
    • 7.4.5 Russia
    • 7.4.6 Nordic
    • 7.4.7 Rest of Europe

8 China

  • 8.1 China Artificial Intelligence Drug R&D Market Size (2015-2026)
  • 8.2 China Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
  • 8.3 China Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
  • 8.4 China Artificial Intelligence Drug R&D Market Size by Region (2015-2020)
    • 8.4.1 China
    • 8.4.2 Japan
    • 8.4.3 South Korea
    • 8.4.4 Southeast Asia
    • 8.4.5 India
    • 8.4.6 Australia
    • 8.4.7 Rest of Asia-Pacific

9 Japan

  • 9.1 Japan Artificial Intelligence Drug R&D Market Size (2015-2026)
  • 9.2 Japan Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
  • 9.3 Japan Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
  • 9.4 Japan Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
    • 9.4.1 Mexico
    • 9.4.2 Brazil

10 Southeast Asia

  • 10.1 Southeast Asia Artificial Intelligence Drug R&D Market Size (2015-2026)
  • 10.2 Southeast Asia Artificial Intelligence Drug R&D Market Size by Type (2015-2020)
  • 10.3 Southeast Asia Artificial Intelligence Drug R&D Market Size by Application (2015-2020)
  • 10.4 Southeast Asia Artificial Intelligence Drug R&D Market Size by Country (2015-2020)
    • 10.4.1 Turkey
    • 10.4.2 Saudi Arabia
    • 10.4.3 UAE
    • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

  • 11.1 IBM Watson
    • 11.1.1 IBM Watson Company Details
    • 11.1.2 IBM Watson Business Overview
    • 11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction
    • 11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2015-2020))
    • 11.1.5 IBM Watson Recent Development
  • 11.2 BioXel
    • 11.2.1 BioXel Company Details
    • 11.2.2 BioXel Business Overview
    • 11.2.3 BioXel Artificial Intelligence Drug R&D Introduction
    • 11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.2.5 BioXel Recent Development
  • 11.3 Insilico Medicine
    • 11.3.1 Insilico Medicine Company Details
    • 11.3.2 Insilico Medicine Business Overview
    • 11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction
    • 11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.3.5 Insilico Medicine Recent Development
  • 11.4 Gatehouse Bio
    • 11.4.1 Gatehouse Bio Company Details
    • 11.4.2 Gatehouse Bio Business Overview
    • 11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction
    • 11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.4.5 Gatehouse Bio Recent Development
  • 11.5 Google DeepMind
    • 11.5.1 Google DeepMind Company Details
    • 11.5.2 Google DeepMind Business Overview
    • 11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction
    • 11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.5.5 Google DeepMind Recent Development
  • 11.6 Genpact Cora
    • 11.6.1 Genpact Cora Company Details
    • 11.6.2 Genpact Cora Business Overview
    • 11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction
    • 11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.6.5 Genpact Cora Recent Development
  • 11.7 Cyclica Inc
    • 11.7.1 Cyclica Inc Company Details
    • 11.7.2 Cyclica Inc Business Overview
    • 11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction
    • 11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.7.5 Cyclica Inc Recent Development
  • 11.8 QuantumBlack
    • 11.8.1 QuantumBlack Company Details
    • 11.8.2 QuantumBlack Business Overview
    • 11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction
    • 11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.8.5 QuantumBlack Recent Development
  • 11.9 Nq Medical
    • 11.9.1 Nq Medical Company Details
    • 11.9.2 Nq Medical Business Overview
    • 11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction
    • 11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.9.5 Nq Medical Recent Development
  • 11.10 Phenomic AI
    • 11.10.1 Phenomic AI Company Details
    • 11.10.2 Phenomic AI Business Overview
    • 11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction
    • 11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 11.10.5 Phenomic AI Recent Development
  • 11.11 Palantir Technologies
    • 10.11.1 Palantir Technologies Company Details
    • 10.11.2 Palantir Technologies Business Overview
    • 10.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction
    • 10.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2015-2020)
    • 10.11.5 Palantir Technologies Recent Development

12Analyst's Viewpoints/Conclusions

    13Appendix

    • 13.1 Research Methodology
      • 13.1.1 Methodology/Research Approach
      • 13.1.2 Data Source
    • 13.2 Disclaimer

    Artificial Intelligence Drug R&D market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Intelligence Drug R&D market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

    Market segment by Type, the product can be split into
    AI Platfrom
    Analytics Service

    Market segment by Application, split into
    Drug Discovery
    Precision Medicine

    Based on regional and country-level analysis, the Artificial Intelligence Drug R&D market has been segmented as follows:
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Nordic
    Rest of Europe
    Asia-Pacific
    China
    Japan
    South Korea
    Southeast Asia
    India
    Australia
    Rest of Asia-Pacific
    Latin America
    Mexico
    Brazil
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE
    Rest of Middle East & Africa

    In the competitive analysis section of the report, leading as well as prominent players of the global Artificial Intelligence Drug R&D market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
    The key players covered in this study
    IBM Watson
    BioXel
    Insilico Medicine
    Gatehouse Bio
    Google DeepMind
    Genpact Cora
    Cyclica Inc
    QuantumBlack
    Nq Medical
    Phenomic AI
    Buy now